SCA
CYTR

SAC Capital Advisors’s CytRx Corp CYTR Stock Holding History

SAC Capital Advisors’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-34,183
Closed -$1.29M – 2195
2013
Q4 		$1.29M Buy
+34,183
New +$623K 0.01% 833

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

SAC Capital Advisors's CYTR Position: Q1 2014 in Review

SAC Capital Advisors sold out of CytRx Corp (CYTR) in Q1 2014, closing a stake of 34,183 shares — an estimated $1.29M sold.

SAC Capital Advisors first reported a position in CYTR in Q4 2013 and held it in 1 quarter. The position peaked at $1.29M in Q4 2013. 62 funds tracked by Wall St. Rank hold CYTR as of Q1 2014.

  • SAC Capital Advisors reported no remaining CytRx Corp position as of Q1 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 34,183 CytRx Corp shares in Q1 2014, an estimated $1.29M.
  • SAC Capital Advisors first reported a position in CytRx Corp in Q4 2013 and held it in 1 quarter.
  • SAC Capital Advisors's CytRx Corp position peaked at $1.29M in Q4 2013.
  • 62 funds tracked by Wall St. Rank held CytRx Corp as of Q1 2014.

Based on SAC Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.